Business, energy, technology, markets and global industry news from Business News Today

sepsis

PharmaDeviceNews sepsis
Representative image: A generic diagnostic test setup illustrates how blood-based lateral flow testing could support Ebola triage and treatment monitoring as VolitionRx advances patent protection for its Nu.Q NETs platform.
Medical Devices & Diagnostics

Why VolitionRx is positioning Nu.Q NETs beyond sepsis and into Ebola monitoring

Find out how VolitionRx’s Nu.Q NETs patent filing could reshape Ebola triage, outbreak diagnostics, and treatment monitoring.

Read More
Representative image of a rapid diagnostic system used in hospital laboratories, reflecting how Pattern Bioscience’s pneumonia ID AST panel aims to deliver faster phenotypic results for critically ill patients and improve antibiotic decision making in ICU settings.
Medical Devices & Diagnostics

Is culture-free pneumonia testing finally viable as Pattern Bioscience nears regulatory submission

Pattern Bioscience advances rapid pneumonia diagnostics toward FDA clearance. Discover what this means for ICU care and antibiotic resistance.

Read More
Representative image of ICU-based sepsis care and immune pathway monitoring, relevant to the EMBRACE clinical trial evaluating emapalumab in interferon-gamma-driven sepsis (IDS).
Pharma & Biotech

Sepsis breakthrough? What the EMBRACE trial reveals about Sobi’s emapalumab strategy

Swedish Orphan Biovitrum AB (Sobi) has reported positive topline data from the Phase 2a EMBRACE trial of Gamifant (emapalumab) in interferon-gamma-driven sepsis (IDS), demonstrating organ function improvement and a potential survival benefit. Based on the signal, the drug will advance in development in collaboration with the Hellenic Institute for the Study of Sepsis (HISS). The

Read More